Endogenous serum glucocorticoid concentrations, steroidogenic enzyme activity and 90-day mortality in patients hospitalized with COVID-19: an observational cohort study

Clara Lundetoft Clausen,Trine Holm Johannsen,Niels Erik Skakkebæk,Hanne Frederiksen,Anders Juul,Thomas Benfield

DOI: https://doi.org/10.1530/ec-24-0093

2024-06-22

Endocrine Connections

Abstract:In the context of severe COVID-19 illness, we examined endogenous glucocorticoid concentrations, steroidogenic enzyme activity, and their correlation with inflammation and patient outcomes. This observational study included 125 hospitalized COVID-19 patients and 101 healthy individuals as a reference group. We used liquid-chromatography-mass spectrometry to assess serum concentrations of 11-deoxycortisol, cortisol, and cortisone, and activities of steroidogenic enzymes (11β-hydroxylase and 11β-hydroxysteroid-dehydrogenase-type-1). Cox proportional hazards regression analysis and competing risk analysis were employed to analyze associations between glucocorticoid concentrations and outcomes, adjusting for relevant factors. In patients with COVID-19, cortisol concentrations were higher and cortisone concentrations were lower compared to the reference group, while 11-deoxycortisol concentrations were similar. Steroidogenic enzyme activity favored cortisol production. Correlations between glucocorticoid concentrations and inflammatory markers were low. A doubling in concentrations cortisol, was associated with increased 90-day mortality and mechanical ventilation (HR2.40 95% CI (1.03-5.59), p=0.042 and HR 3.83 (1.19-12.31), p=0.024). A doubling in concentrations of 11-deoxycortisol was also associated to mortality (HR 1.32 (1.05-1.67), p=0.018), whereas concentrations of cortisone were associated with mechanical ventilation (HR 5.09 (1.49-17.40), p=0.009)). In conclusion, serum concentrations of glucocorticoid metabolites were altered in patients hospitalized with severe COVID-19, and steroidogenic enzyme activity resulting in the conversion of cortisone to biologically active cortisol was preserved, thus not favoring critical-illness-related-corticosteroid-insufficiency at the enzymatic level. Glucocorticoid release did not counterbalance the hyperinflammatory state in patients with severe COVID-19. High serum concentrations of 11-deoxycortisol and cortisol were associated with 90-day mortality, and high serum concentrations of cortisol and cortisone were associated with mechanical ventilation.

endocrinology & metabolism